Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 2001, p. 1654-1656, Vol. 39, No. 4
Department of Veterinary Food
Inspection1 and Department of Pathology,
Bacteriology and Poultry Diseases,2 Faculty of
Veterinary Medicine, Ghent University, 9820 Merelbeke, and
Department of Microbiology, Faculty of Sciences, Ghent
University, 9000 Ghent,3 Belgium
Received 16 October 2000/Returned for modification 28 December
2000/Accepted 22 January 2001
Several antimicrobial agents used in selective media for the
isolation of Arcobacter were found to be inhibitory to
strains belonging to this genus. All three species tested were
susceptible to colistin and rifampin at concentrations used in
selective media. Arcobacter skirrowii was the most
susceptible species. 5-Fluorouracil, novobiocin, trimethoprim, and
teicoplanin or vancomycin were found to be without any inhibitory
effect on the strains tested at concentrations described for the
isolation of Arcobacter species.
Arcobacter species rarely
occur as the only or the dominant bacteria in different types of
samples from animals, foods, and water. Two species, Arcobacter
butzleri and Arcobacter cryaerophilus are associated
with human diarrheal illness and bacteremia, but their pathogenic role
is unclear. Although antimicrobial agents have to be used in enrichment
broths and plating media (5, 7, 8) the exact
susceptibility of arcobacters to these agents never has been specified.
Limited data are available on the susceptibility of A. butzleri and the A. cryaerophilus subgroups to certain
substances (10), and nothing is known on the activity of
these agents against A. skirrowii.
The aim of the present study was to determine the MICs of the
most common antimicrobial agents used for the isolation of the three
animal-associated Arcobacter species, in order to determine the usefulness of the selective supplements in the isolation protocols for arcobacters and thermophilic campylobacters. Another goal of this
study was to determine whether antimicrobial susceptibility patterns
could be used to differentiate the three Arcobacter species that are recovered from humans and food animals.
A total of 111 strains of Arcobacter species were obtained
from the BCCM/LMG Bacteria collection, Ghent University (Ghent, Belgium). These strains originated from human, food, animal, and environmental sources and belonged to the species A. butzleri, A. cryaerophilus subgroup 1 and 2, and A. skirrowii (Table
1). Twelve antimicrobial agents (Table
2) obtained as laboratory standard powders from Sigma, St. Louis, Mo. were dissolved and further
diluted and added to Mueller Hinton II agar (Becton Dickinson, Cockeysville, Md.) as recommended by the National Committee for Clinical Laboratory Standards (NCCLS document M100-S7)
(11). Plates were seeded by a Steers inoculum replicator
(MAST, London, United Kingdom) with approximately 105 CFU
of appropriately diluted strains grown overnight in brain heart
infusion (Oxoid, Basingstoke, United Kingdom). All incubations were at
30°C under microaerobic conditions created by evacuating 80% of the
normal atmosphere and introducing a gas mixture of 8% CO2,
8% H2, and 84% N2.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.4.1654-1656.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Susceptibility of Arcobacter butzleri,
Arcobacter cryaerophilus, and Arcobacter skirrowii to
Antimicrobial Agents Used in Selective Media
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
TABLE 1.
Origins of the collection strains used in this study
TABLE 2.
Distribution of MICs for 47 A. butzleri, 46 A. cryaerophilus, and 18 A. skirrowii collection
strains of human, animal, and environmental origin
The MICs of the 12 antimicrobial agents tested (Table 2) did not show
consistent differences between the species tested, although in general
A. skirrowii isolates were more susceptible than were
A. butzleri and A. cryaerophilus. All 111 isolates tested were highly resistant (MIC > 256 µg/ml) to the
two antifungal agents, amphotericin B and cycloheximide, as well as to
5-fluorouracil. Most strains were resistant to novobiocin, and variable
susceptibility was noted for piperacillin, trimethoprim, and
vancomycin. MICs of piperacillin were
32 µg/ml for 17 A. skirrowii strains, but one strain was resistant (MIC of 256 µg/ml). Two strains of A. cryaerophilus subgroup 2 showed
high resistance levels to bacitracin (MIC > 256 U/ml), and three
strains of the same group showed decreased susceptibility to rifampin.
Cefotaxime was more active than cefoperazone, the other cephalosporin tested.
These findings offer an explanation for certain observations reported in the literature and can be used to select or to design improved Arcobacter isolation protocols. Many of the A. skirrowii and A. cryaerophilus strains were found to be susceptible to piperacillin at a concentration of 64 µg/ml, a level which is only slightly lower than the 75 µg/ml added by de Boer et al. in their selective medium (5). This probably explains why A. butzleri was the only species isolated by these authors. Also, the inclusion of cefoperazone at 32 µg/ml in this medium as well as in others (2, 8, 9) may be detrimental to stressed or injured cells of A. cryaerophilus and A. skirrowii. The cefoperazone MIC levels are only marginally above this concentration. The results obtained in the present MIC study and in the one of Kiehlbauch et al. (10) suggest that the media with CVA and CIN selective supplements described by Collins et al. (4) may be useful for the isolation of A. butzleri and A. cryaerophilus but not for A. skirrowii. It can be concluded that the use of those supplements is not appropriate when the recovery of the all three Arcobacter species is pursued.
Based on the MICs obtained in this study and the activity of teicoplanin being comparable to that of vancomycin, the CAT supplement (cefoperazone at 8 µg/ml, amphotericin B at 10 µg/ml, and teicoplanin at 4 µg/ml) used by Atabay et al. (1) appears to be appropriate for the recovery of the three Arcobacter species. However, this medium does not sufficiently suppress contaminating flora in poultry neck skin (6). The same remark holds true for 5-fluorouracil used in EMJH medium.
Another problem concerns the selectivity of Campylobacter selective isolation procedures. It is not clear whether or not Campylobacter-like bacterial growth appearing on these plates may be identified as Campylobacter without further testing because arcobacters are not fully inhibited. All three Arcobacter species are susceptible to colistin (polymyxin E) and rifampin, two important components of these media. Considering that polymyxin B has the same antimicrobial activity as colistin, arcobacters can be considered to be susceptible to polymyxin B as was found for A. butzleri and A. cryaerophilus (10). However, from results obtained in the present investigation as well as in the study by Kiehlbauch et al. (10), it appears that only the Butzler medium (4) containing colistin at 10 U/ml and rifampin at 10 µg/ml fully inhibits arcobacters. The concentrations of polymyxin B and rifampin are lower in other media, such as Blaser-Wang, Skirrow, and Preston media, and probably only marginally effective.
In conclusion, only enrichments in EMJH medium with 5-fluorouracil or in Arcobacter broth with the CAT supplement fully support growth of the three Arcobacter species tested. However, none of the presently available supplements fully suppresses the accompanying flora in biological samples. As shown by the MICs in the present study, A. skirrowii is the most susceptible species, and this can be an explanation for the low recoveries reported to date for this species. Antimicrobial agents that can be used in selective media include 5-fluorouracil, novobiocin, trimethoprim, and cefoperazone at appropriate concentrations.
| |
ACKNOWLEDGMENTS |
|---|
We thank the BCCM/LMG Bacteria Collection, Ghent University, for providing the Arcobacter collection strains used in this study.
The skilled technical assistance provided by Arlette Van de Kerckhove and Severine Laevens is greatly appreciated.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Veterinary Food Inspection, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium. Phone: 32 09 264 74 51. Fax: 32 09 264 74 91. E-mail: kurt.houf{at}rug.ac.be.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Atabay, H. I., and J. E. L. Corry. 1998. Evaluation of a new Arcobacter enrichment medium and comparison with two media developed for enrichment of Campylobacter spp. Int. J. Food Microbiol. 41:53-58[CrossRef][Medline]. |
| 2. |
Bolton, F. J.,
D. N. Hutchinson, and D. Coates.
1984.
Blood-free selective medium for isolation of Campylobacter jejuni from feces.
J. Clin. Microbiol.
19:169-171 |
| 3. | Butzler, J. P., and M. B. Skirrow. 1979. Campylobacter enteritis. Clin. Gastroenterol. 8:737-765[Medline]. |
| 4. | Collins, C., I. Wesley, and E. Murano. 1996. Detection of Arcobacter spp. in ground pork by modified plating methods. J. Food Prot. 5:448-452. |
| 5. | de Boer, E., J. Tilburg, D. Woodward, H. Lior, and W. Johnson. 1996. A selective medium for the isolation of Arcobacter from meats. Lett. Appl. Microbiol. 23:64-66[Medline]. |
| 6. | Houf, K., A. Tutenel, L. De zutter, J. Van Hoof, and P. Vandamme. Development of a multiplex PCR assay for the simultaneous detection and identification of Arcobacter butzleri, Arcobacter cryaerophilus and Arcobacter skirrowii. FEMS Microbiol. Lett. 193:89-94. |
| 7. | Johnson, L. G., and E. A. Murano. 1999. Comparison of three protocols for the isolation of Arcobacter from poultry. J. Food. Prot. 62:610-614[Medline]. |
| 8. | Johnson, L. G., and E. A. Murano. 1999. Development of a new medium for the isolation of Arcobacter spp. J. Food. Prot. 62:456-462[Medline]. |
| 9. |
Karmali, M. A.,
A. E. Simor,
M. Roscoe,
P. C. Fleming,
S. S. Smith, and J. Lane.
1986.
Evaluation of a blood-free, charcoal-based, selective medium for the isolation of Campylobacter organisms from feces.
J. Clin. Microbiol.
23:456-459 |
| 10. |
Kiehlbauch, J. A.,
C. N. Baker, and I. Wachsmuth.
1992.
In vitro susceptibilities of aerotolerant Campylobacter isolates to 22 antimicrobial agents.
Antimicrob. Agents Chemother.
36:717-722 |
| 11. | National Committee for Clinical Laboratory Standards. 1997. Approved standard M7-A4. Scheme for preparing dilutions of antimicrobial agents to be used in agar dilution susceptibility tests. Suggested modifications of standard methods for susceptibility testing of some fastidious and special problem bacteria (M100-S7). NCCLS, Wayne, Pa. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|